Mind Cure Health Inc.
CSE: MCUR, FFT: 6MH
Company Overview
Mind Cure Health Inc. is a mental health and wellness company with a mission to identify and develop products that ease suffering, increase productivity and enhance mental health.
The company’s 5 Spheres framework includes:
- Clinical Research Technology: The company anticipates acquiring diagnostic technologies for use in clinical trials and data collection tools to help clinicians receive patient feedback to improve treatment efficacy.
- Nootropic Formulations: The company is developing nootropic, psychoactive products and substances to promote productivity and enhanced mental health, including products launched under its MoonBeam Mushroom brand.
- Clinical Research: The company intends to evaluate the potential for clinical trials that would benefit mental health and wellness under Health Canada’s industry-leading framework for psychedelic medicines.
- Product Discovery: The company is evaluating the legal and commercial viability of psychedelic compounds such as psilocybin, as well as new and improved psychedelic-inspired candidates, such as non-psychoactive analogs.
- Formulations & Supply: The company is evaluating a path to manufacture, import and supply traditional and novel pharmaceutical agents for North America to satisfy the underserved access to psychoactive compounds APIs for research.
Financial Highlights
$0
Revenue (ttm)
$0
Gross Profit (ttm)
-$0.06
Diluted EPS (ttm)
Management Team
Mr. Stephen D. Inouye
Chief Financial Officer and Director
Ms. Terese J. Gieseleman
Corp. Sec. & Director
Ms. Kelsey Leigh Ramsden
Pres & CEO
Mr. Geoff Belair
Chief Technology Officer
Dr. Ryan V. Hartwell
Chief Science Officer & Member of Scientific Advisory Board
Key Highlights
Market Capitalization
$23,459,518
Shares Outstanding
45,220,000
Shares Short (% of Float)
176,168 (0%)
Insider Ownership
7%